Agencies in the European Regulatory Union

2016 ◽  
Author(s):  
Herwig C.H. Hofmann
Keyword(s):  
European Regulatory

ECPA Crop Protection European Regulatory Conference 2018

2018 ◽  
Vol 29 (3) ◽  
pp. 141-144
Keyword(s):  
Crop Protection ◽  
European Regulatory

The Principle of Shareholder Primacy in Company Law from a Nordic and European Regulatory Perspective

2011 ◽  
Author(s):  
Paul Krüger Andersen ◽  
Evelyne J.B. Sørensen
Keyword(s):  
Company Law ◽  
Shareholder Primacy ◽  
Regulatory Perspective ◽  
European Regulatory

Bond Liquidity and Dealer Inventories: Insights from US and European Regulatory Data

2020 ◽  
Author(s):  
Plamen Ivanov ◽  
Alexei G. Orlov ◽  
Michael Schihl
Keyword(s):  
Regulatory Data ◽  
European Regulatory ◽  
Bond Liquidity

scholarly journals Adverse Drug Reaction Reporting by Patients in 12 European Countries

2021 ◽  
Vol 18 (4) ◽  
pp. 1507
Author(s):  
Agne Valinciute-Jankauskiene ◽  
Loreta Kubiliene
Keyword(s):  
Statistical Analysis ◽  
Adverse Drug Reaction Reporting ◽  
Regulatory System ◽  
European Countries ◽  
Pharmacovigilance System ◽  
Common Source ◽  
Patient Reporting ◽  
Safety Risks ◽  
European Regulatory ◽  
National Competent Authorities

Patients who report suspected adverse drug reactions (ADRs) help minimize drug safety risks and bolster the pharmacovigilance system. The aim of this study was to examine the contribution of patients to pharmacovigilance and compare the tools used to promote patient reporting in European countries that implemented this reporting type in 2012–2013. A web-based questionnaire was sent to the national competent authorities (NCAs) of the European countries. The received answers were systematized and compared using statistical analysis. The performed statistical analysis demonstrated that changes in the number of received ADR reports increased significantly in each country during the analyzed period. These changes were significantly different in Ireland and Finland from those in the other reviewed countries. The common source of information on direct patient reporting was the country’s NCA website. Other sources used were social media pages, leaflets, and posters. This is the first study on patient reporting schemes implemented after the significant reform of the European regulatory system for pharmacovigilance. However, some countries did not actively promote their patient reporting schemes. Our findings indicate that countries with minimal experience in pharmacovigilance systems that include direct patient reporting should organize comprehensive campaigns on ADR reporting.

Medical devices manufactured from latex: European regulatory initiatives

Methods ◽  
2002 ◽  
Vol 27 (1) ◽  
pp. 93-98 ◽  
Author(s):  
W.H. De Jong ◽  
R.E. Geertsma ◽  
J.J.B. Tinkler
Keyword(s):  
Medical Devices ◽  
European Regulatory

scholarly journals Current european regulatory perspectives on insulin analogues

2011 ◽  
Vol 3 (1) ◽  
Author(s):  
Harald G Enzmann ◽  
Martina Weise
Keyword(s):  
Insulin Analogues ◽  
European Regulatory

scholarly journals European regulatory agencies should employ full time statisticians

BMJ ◽  
2008 ◽  
Vol 336 (7638) ◽  
pp. 250-250 ◽  
Author(s):  
Sara Hughes
Keyword(s):  
Regulatory Agencies ◽  
Full Time ◽  
European Regulatory

European regulatory aspects of phage therapy: magistral phage preparations

2022 ◽  
Vol 52 ◽  
pp. 24-29
Author(s):  
Gilbert Verbeken ◽  
Jean-Paul Pirnay
Keyword(s):  
Phage Therapy ◽  
Regulatory Aspects ◽  
European Regulatory

scholarly journals Animal by-products for feed: characteristics, European regulatory framework, and potential impacts on human and animal health and the environment

2016 ◽  
Vol 25 (3) ◽  
pp. 189-202 ◽  
Author(s):  
D. Jędrejek ◽  
J. Levic ◽  
J. Wallace ◽  
W. Oleszek
Keyword(s):  
Animal Health ◽  
Regulatory Framework ◽  
European Regulatory ◽  
By Products
Sign in / Sign up

Export Citation Format

Share Document